The class II transactivator (CIITA) is a transcriptional master regulator of class II MHC genes, discovered by complementation cloning of an HLA-D-negative mutant cell line. Defective CIITA leads to a type of severe immunodeficiency in humans, the Group A, type II Bare Lymphocyte Syndrome (BLS). CIITA controls the expression of conventional class II MHC genes, as well as DM, Doalpha and Ii genes. It is a potent activator which causes the activation of class II MHC promoters by up to 100 fold. It controls promoters which contain class II MHC promoter elements, W, X and Y, yet it is not a DNA-binding protein. The mechanism by which CIITA activates class II MHC promoters and its novel target genes has been, and continues to be, the focus of this proposal. Experiments performed during the last grant period have shown that CIITA operates by interaction with the DNA- binding transcription factors, NF-Y and RFX, which control class II MHC promoters. Additionally, CIITA opens class II MHC promoters in vivo as determined by genomic footprinting. The purpose of the first half of this proposal is to understand how CIITA control class II MHC genes at the molecular level. The first two Aims continue to investigate how CIITA alters gene expression, and they are: (1) To further examine a HAT-like domain within CIITA which is associated with histone acetylase activity; (2) to determine if CIITA alters other aspects of chromatin opening by studying changes in intact cells. The purpose of the second half of the proposal is to understand if CIITA controls other genes, how this control is executed, and if these target genes have relevant biologic functions. During the last grant period, we show that CIITA may control other genes and biologic processes as revealed by differential gene screen analysis and by comparing primary cells obtained from CIITA gene knockout mice with wildtype controls. To continue this line of inquiry, the last two Aims are (3) to understand the molecular mechanism by which CIITA controls non-class II MHC genes; and (4) determine if these genes are relevant in antigen presenting cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI029564-15
Application #
6895595
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Macchiarini, Francesca
Project Start
1991-07-01
Project End
2007-09-23
Budget Start
2005-06-01
Budget End
2007-09-23
Support Year
15
Fiscal Year
2005
Total Cost
$326,074
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Huang, Juin-Hua; Liu, Chu-Yu; Wu, Sheng-Yang et al. (2018) NLRX1 Facilitates Histoplasma capsulatum-Induced LC3-Associated Phagocytosis for Cytokine Production in Macrophages. Front Immunol 9:2761
Truax, Agnieszka D; Chen, Liang; Tam, Jason W et al. (2018) The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis. Cell Host Microbe 24:364-378.e6
Zhang, Song; Takaku, Motoki; Zou, Liyun et al. (2017) Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation. Nature 551:105-109
Rotty, Jeremy D; Brighton, Hailey E; Craig, Stephanie L et al. (2017) Arp2/3 Complex Is Required for Macrophage Integrin Functions but Is Dispensable for FcR Phagocytosis and In Vivo Motility. Dev Cell 42:498-513.e6
Koblansky, A Alicia; Truax, Agnieszka D; Liu, Rongrong et al. (2016) The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals. Cell Rep 14:2562-75
Aachoui, Youssef; Kajiwara, Yuji; Leaf, Irina A et al. (2015) Canonical Inflammasomes Drive IFN-? to Prime Caspase-11 in Defense against a Cytosol-Invasive Bacterium. Cell Host Microbe 18:320-32
Guo, Haitao; Gao, Jianmei; Taxman, Debra J et al. (2014) HIV-1 infection induces interleukin-1? production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes. J Biol Chem 289:21716-26
Rodgers, Mary A; Bowman, James W; Fujita, Hiroaki et al. (2014) The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. J Exp Med 211:1333-47
Wen, Haitao; Miao, Edward A; Ting, Jenny P-Y (2013) Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 39:432-41
Taxman, Debra J; Swanson, Karen V; Broglie, Peter M et al. (2012) Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis. J Biol Chem 287:32791-9

Showing the most recent 10 out of 46 publications